美股全線收跌 霧芯科技重挫19%
格隆匯12月1日丨美股全線收跌,道指跌1.86%,納指跌1.55%,標普500指數跌1.90%。大型科技股多數下跌,奈飛跌3.31%,谷歌跌2.5%,臉書跌4.01%,微軟跌1.79%,亞馬遜跌1.53%,蘋果漲3.16%。Moderna跌逾4%,公司CEO此前預計現有疫苗在應對奧密克戎方面的效果將遠不如應對早期新冠毒株。熱門中概股多數下跌,電子煙國標開始徵求意見,霧芯科技暴跌19%。荔枝跌15.87%,達達集團跌15.4%,迅雷跌9.27%,拼多多跌7.59%,京東跌4.32%,阿裏巴巴跌3.15%,小鵬汽車漲7.01%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.